AstraZeneca has followed others in saying it could suspend further investment in the United Kingdom unless the government reforms what its chairman described as an “antiquated and appalling” drug pricing system. …
AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime
October 7, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Proteomics International secures WA Government grant to advance world-first blood test for endometriosis
November 9, 2025 - - Australian Biotech -
AVITA Medical narrows losses and secures EU approval as reimbursement challenges ease
November 9, 2025 - - Australian Biotech -
From potential to practice - AI Health Summit to focus on adoption, implementation and governance
November 9, 2025 - - Latest News -
Call for national action to lift immunisation rates as whooping cough spread worsens
November 9, 2025 - - Latest News -
Pharmacy Guild - 'You can’t fragment care you’re not receiving'
November 8, 2025 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 7 November
November 7, 2025 - - Podcast -
Donald Trump announces 'MFN' deals with Lilly and Novo Nordisk and end to 'global freeloading'
November 7, 2025 - - Latest News